statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Bitcoin

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Invesco QQQ Trust Series 1

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Insider Sell: Cytek Biosciences Inc's (CTKB) Chief Technology Officer Ming Yan Sells 40,000 Shares

Experienced executive with extensive background as CFO for global corporations across dynamic sectors Cytek reaffirms 2024 outlook FREMONT, Calif., March 19, 2024 (GLOBE NEWSWIRE) -- Cytek...

Cytek  Biosciences Names William McCombe Chief Financial Officer

Cytek Biosciences (NASDAQ:CTKB  Get Free Report) had its target price cut by equities researchers at Piper Sandler from $11.00 to $10.00 in a report issued on Wednesday, Benzinga reports. The...

Cytek Biosciences (NASDAQ:CTKB) PT Lowered to $10.00

Cytek Wuxi Facility

 Cytek's new 50,000-square-foot facility in Wuxi, China increases the company's manufacturing capacity to meet the growing worldwide demand for comprehensive cell...

Cytek  Biosciences Opens New Facility to Address Increasing Global Demand for Cutting-Edge Cell Analysis Solutions

Cytek Biosciences, Inc. (NASDAQ:CTKB  Get Free Report)s stock price dropped 6.5% during mid-day trading on Wednesday after Piper Sandler lowered their price target on the stock from...

Cytek Biosciences (NASDAQ:CTKB) Trading Down 6.5% on Analyst Downgrade

In a report released today, David Westenberg from Piper Sandler maintained a Buy rating on Cytek Biosciences (CTKB Research Report), with a price...

Piper Sandler Reaffirms Their Buy Rating on Cytek Biosciences (CTKB)

See the rest of the story here.

thefly.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fly's real-time, streaming news feed keeps individual...

Cytek Biosciences price target lowered by $1 at Piper Sandler, here's why

In trading on Wednesday, shares of Cytek BioSciences Inc (CTKB) crossed below their 200 day moving average of 7.56, changing hands as low as 7.05 per share. Cytek BioSciences Inc shares...

Cytek BioSciences (CTKB) Shares Cross Below 200 DMA

Cytek Biosciences (NASDAQ:CTKB  Free Report) had its price target increased by The Goldman Sachs Group from $9.00 to $10.00 in a research report sent to investors on Thursday, Benzinga...

Cytek Biosciences (NASDAQ:CTKB) Given New $10.00 Price Target at The Goldman Sachs Group

Cytek Biosciences (NASDAQ:CTKB  Free Report) had its price target boosted by The Goldman Sachs Group from $9.00 to $10.00 in a research report released on Thursday, Benzinga reports. The...

The Goldman Sachs Group Boosts Cytek Biosciences (NASDAQ:CTKB) Price Target to $10.00

Cytek Biosciences, Inc. is a life sciences technology company, which engages in the provision of cell analysis tools by leveraging novel technical approaches. Its products include Cytek Aurora CS, Cytek Aurora, Cytek Northern Lights, and Cytek NL-CLC. The company was founded by Wenbin Jiang and Ming Yan in 1992 and is headquartered in Fremont, CA.

Volume	738,574.00
52-Wk High	$11.88
52-Wk Low	$3.80

CTKB Cytek BioSciences Inc

About

Feed

News

Sentiment

Earnings

Fundamentals